edited by Carlo Di Mario, George D. Dangas, Peter Barlis ; forewords by Patrick W. Serruys and Martin B. Leon
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Hoboken, NJ :
Name of Publisher, Distributor, etc.
Wiley-Blackwell,
Date of Publication, Distribution, etc.
2009
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
xvi, 576 p. :
Other Physical Details
ill. (some col.) ;
Dimensions
27 cm. +
Accompanying Material
1 DVD-ROM (4 3/4in.)
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index
CONTENTS NOTE
Text of Note
Interventional cardiology training -- Atherogenesis and inflammation -- The essentials of vascular access and closure -- Optimal angiographic views for coronary angioplasty -- Material selection -- Physiologic assessment in the cardiac catheterization laboratory -- Quantitative coronary and vascular angiography -- Oral antiplatelet agents in PCI -- Heparin, LMWH, GIIb/IIIa, and direct thrombin inhibitors -- Intravascular ultrasound: principles, image interpretation, and clinical applications-- Principles of intra-coronary optical coherence tomography -- Multislice computed tomography of coronary arteries -- Cardiac magnetic resonance imaging -- Stable angina -- Indications in acute coronary syndromes without ST elevation (NSTE-ACS) -- Primary and rescue PCI in acute myocardial infarction -- Chronic total coronary occlusion -- Percutaneous coronary intervention in unprotected left main -- Bifurcation lesions -- Approach to multivessel coronary artery disease -- Rotational atherectomy -- Thrombectomy and embolic protection -- Carotid artery angioplasty and stenting -- Aortic valve disease intervention -- Transseptal puncture -- Alcohol septal ablation for hypertrophic obstructive cardiomyopathy -- Cell therapy -- No reflow -- The management of cardiogenic shock -- In-stent restenosis in the DES era -- Renal insufficiency and the impact of contrast agents -- Coronary artery dissection and perforation -- Statistical essentials in the design and analysis of clinical trials -- Sirolimus and paclitaxel eluting stent clinical studies -- Zotarolimus eluting stents clinical studies -- Everolimus eluting coronary stents: clinical trials -- Novel drug eluting stent systems